Kristin E. Anton

<i>In vitro</i> Selection and Characterization of HIV-1 with Reduced Susceptibility to PMPA

Mark A. Wainberg, Michael D. Miller, Yudong Quan et al. · Antiviral Therapy · 1999 · 247 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

Human Immunodeficiency Virus Type 1 Expressing the Lamivudine‐Associated M184V Mutation in Reverse Transcriptase Shows Increased Susceptibility to Adefovir and Decreased Replication Capability In Vitro

Michael D. Miller, Kristin E. Anton, Andrew Mulato et al. · The Journal of Infectious Diseases · 1999 · 133 citations · Full text

Life Sciences, Infectious Diseases, Pharmacokinetics +17

Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 Variants Isolated from AIDS Patients after Prolonged Adefovir Dipivoxil Therapy

Andrew Mulato, Patrick D. Lamy, Michael D. Miller et al. · Antimicrobial Agents and Chemotherapy · 1998 · 38 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Adefovir and Tenofovir Susceptibilities of HIV-1 After 24 to 48 Weeks of Adefovir Dipivoxil Therapy: Genotypic and Phenotypic Analyses of Study GS-96-408

Michael D. Miller, Nicolas Margot, Patrick D. Lamy et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 31 citations

Medicine, Pharmacology, Pharmacotherapy +17